Cytosorbents | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Granahan Investment Management LLC(3.85%)
Cytosorbents | 10-Q: Q3 2024 Earnings Report
Cytosorbents | 8-K: CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Officer Deliargyris Efthymios
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Officer Capponi Vincent
Cytosorbents | 8-K: Current report
Cytosorbents | 424B5: Prospectus
Cytosorbents | 8-K: Current report
Cytosorbents | EFFECT: Others
Cytosorbents | CORRESP: CORRESP
Cytosorbents | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Cytosorbents | 8-K: Current report
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Officer MARIANI PETER J
Cytosorbents | 3: Initial statement of beneficial ownership of securities-Officer MARIANI PETER J
Cytosorbents | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cytosorbents | 8-K: Current report
Cytosorbents | 8-K: CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
Cytosorbents | 10-Q: Q2 2024 Earnings Report
Cytosorbents | 8-K: Current report
Cytosorbents | UPLOAD: Others
No Data
No Data